Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cloudflare Inc (NET) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Cloudflare IncTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Cloudflare Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Cloudflare Inc trades at $310 (market cap $109.31B), while State Street SPDR S&P Biotech ETF trades at $159.33. Which is the better fit depends on your goals.

NETXBI
Market Cap
$109.31B
Sector
TechnologyBroad Market / Factor
52-Week High
$310.40$164.28
52-Week Low
$160.16$86.92
Enterprise Value
$108.67B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cloudflare Inc

Cloudflare (NET) trades at $310.91, up 0.16% with strong technical momentum and bullish moving averages. The company shows robust revenue growth (36% in Q2 2026) and expanding gross margins (72.58%), though it remains unprofitable with a -8.21% net margin. Recent news highlights AI-driven demand and a $2.175 billion convertible note offering, while analyst consensus remains strongly bullish with a $337.10 price target.

The outlook remains positive given strong execution and AI tailwinds, but investors face risks from premium valuation (P/S 42.99), ongoing losses, and competitive pressures. Institutional sentiment is supportive with 72.5% buy ratings, though the stock's proximity to all-time highs warrants caution amid elevated expectations.

State Street SPDR S&P Biotech ETF

XBI trades at $158.81, up 0.49% today, with a bullish technical signal supported by moving averages. The ETF shows strong momentum with a 17% monthly gain and 75% annual return, driven by biotech sector strength. Analyst coverage is limited to one hold rating, while recent news highlights institutional buying interest and positive sector developments including M&A activity and drug trial successes.

The outlook remains positive given biotech's breakout from multi-year bear markets, though elevated volatility and policy risks persist. Key opportunities include AI-driven drug discovery and sustained M&A momentum, while risks involve sector-specific volatility and regulatory uncertainty. The ETF's equal-weight approach provides diversified exposure to biotech innovation.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cloudflare Inc

Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.

Read more on NET

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI